Approved IV drug reduces lupus symptoms, clinical trial finds
by Dennis Thompson edited by Sadie Harley, reviewed by Andrew Zinin Editors’ notes The GIST Add as preferred source An already-approved IV drug significantly reduces the symptoms of lupus, a new clinical trial showed. More than three-quarters of lupus patients taking obinutuzumab (Gazvya) had a significant improvement in their symptoms after a year on the drug, researchers […]
Approved IV drug reduces lupus symptoms, clinical trial finds Read More »
